{"product_id":"semax-10mg","title":"Semax 10mg","description":"\u003ch3\u003eWith \u003cstrong\u003e\u003cem\u003eFREE\u003c\/em\u003e\u003c\/strong\u003e BAC Water\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCOAs available upon request\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eSemax Peptide\u003c\/span\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cspan\u003eOverview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSemax is a laboratory-produced peptide developed from the ACTH (adrenocorticotropic hormone) 4–10 sequence and was first created by researchers in Russia. Unlike the original hormone, Semax does not exhibit corticosteroid activity, making it an attractive candidate for investigating neurological function without the hormonal effects associated with ACTH.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePreclinical and laboratory research has focused on Semax for its potential involvement in cognitive performance, neuroprotection, and the body's adaptive response to stress. Although it is not approved for therapeutic use in most countries, Semax continues to be extensively studied in neuroscience and peptide research.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSemax has been investigated across a number of experimental research areas, including:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eNeuroprotection\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eLaboratory studies have explored Semax for its potential to support neuronal survival and reduce oxidative damage in models of cerebral ischemia and traumatic brain injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eCognitive Function\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eResearchers have examined its possible nootropic properties, including effects on memory formation, learning processes, concentration, and attention.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eMood and Neurotransmitter Activity\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003ePreclinical investigations suggest that Semax may influence neurotransmitter systems, particularly those involving dopamine and serotonin, making it an area of interest in behavioural and neurological research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eNeurotrophic Signalling\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eStudies have also evaluated Semax for its potential effects on the expression of brain-derived neurotrophic factor (BDNF) and other proteins involved in neuronal growth, plasticity, and repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eCollectively, these areas of investigation have established Semax as an important research peptide for studying cognitive function, neurological resilience, and mechanisms involved in brain health and recovery.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTechnical Specifications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eChemical Name:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Met-Glu-His-Phe-Pro-Gly-Pro\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eAlternative Names:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Semax; ACTH(4–7)-Pro-Gly-Pro\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eMolecular Formula:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e C₃₇H₅₁N₉O₁₀S\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eMolecular Weight:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Approximately 751.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eAmino Acid Sequence:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e MEHFPGP\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eCAS Number:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 80714-61-0\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003ePeptide Classification:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Synthetic heptapeptide derived from the ACTH (4–10) fragment\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eStorage Recommendations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003eLyophilized Semax is stable at room temperature for short-term handling.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eFor long-term preservation, store at \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e−20 °C or colder\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eFollowing reconstitution, refrigerate at \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e2 °C to 8 °C\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Stability after mixing may vary depending on the solvent and storage conditions.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eSolubility\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSemax readily dissolves in sterile water and compatible aqueous buffer solutions, with solubility influenced by the peptide's purity and formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eReferences\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eAlekseeva, E. V., Andreeva, L. A., Kamensky, A. A., et al. (1992). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eNeuropeptide Semax: behavioral effects and mechanism of action.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Neuroscience and Behavioral Physiology, 22(6), 475–479.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eMyasoedov, N. F., Kamensky, A. A., \u0026amp; Ashmarin, I. P. (1997). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePeptide Semax in the prevention and treatment of experimental cerebral ischemia.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Pathophysiology, 4(4), 273–277.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInozemtsev, A. N., Kamensky, A. A., \u0026amp; Ashmarin, I. P. (2008). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eSemax and neurotrophin expression: insights into peptide modulation of the nervous system.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Doklady Biological Sciences, 418(1), 17–19.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cem\u003e\u003cstrong\u003eResearch compound only. Not for human consumption\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":54735587475785,"sku":null,"price":32.5,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/7493\/3833\/files\/Semax10mg.png?v=1782667815","url":"https:\/\/truformlabs.co.uk\/products\/semax-10mg","provider":"TruForm Labs","version":"1.0","type":"link"}